#TALK Research - Middlemore Clinical Trials Newsletter
21/12/2022
We would like to share with you our plans to change the name of Middlemore Clinical Trials.
Read more
Study reveals recommended anticoagulant therapy for COVID patients
13/12/2022
The AustralaSian COVID-19 Trial (ASCOT) has pinpointed the most efficient level of blood thinning treatment needed for patients hospitalised with COVID-19, in a study published in the New England Journal of Medicine Evidence and presented at the American Society for Hematology conference today.
Read more
Middlemore Clinical Trials Annual Report FY22
19/10/2022
in bringing novel clinical trials to the community of Counties Manukau.
Read more
August #TALK.Research Newsletter CMH_PI_HoD
10/08/2022
than ever before and enrolled more participants than any preceding year.
Read more
Kiwi women taking part in global trial of RSV vaccine
04/05/2022
RSV causes lung and respiratory tract infections and is highly contagious, there is no effective vaccine or cure for it. The virus is usually not serious for adults and older children but infants and premature babies can become very sick. Pfizer is carrying out the vaccine trial, which is currently in phase three and is given to pregnant women rather than the baby.
Read more
#TALK Research - Middlemore Clinical Trials Newsletter
08/03/2022
The requests for Middlemore Clinical Trials to be involved in clinical trials has never been greater.
Read more
Spotlight on the Renal Department
02/03/2022
March is Kidney Health month, which is an opportunity to highlight the great work the Renal department does for the Counties Manukau catchment.
Read more
Spotlight on the Haematology Department
09/12/2021
The Haematology department at Middlemore Hospital are unique in that all six consultants are actively involved in clinical research. The team are very busy with a combination of commercial and grant-funded trials as well as their clinic responsibilities.
Read more
NPSIMS™ Device Trial Update
10/11/2021
We are proud to have coordinated this first-in-human-open label clinical study with Principal Investigator Mr Jon Mathy in Plastic surgery and Mr Alpesh Patel in Spinal surgery.
Read more
Annual Report 2021 Published
18/10/2021
Middlemore Clinical Trials is pleased to present our Annual Report 2021.
Read more
ASCOT - The Australasian COVID-19 Trial
01/10/2021
The AustralaSian COVID-19 Trial, is a multi-centre randomised adaptive platform clinical trial to assess clinical, virological, and immunological outcomes in patients with SARS-CoV-2 infection (COVID-19). The New Zealand arm of the study is led by CM Health clinical microbiologist and infectious disease consultant, Dr Susan Morpeth.
Read more
Artificial Intelligence and Keratoconus - Dr Rasha Al Taie (Ophthalmologist)
31/03/2021
CM Health ophthalmologist and new researcher to MMCT, Dr Rasha Al Taie, has recently been successful in receiving funding from the Potters Masonic Trust, with help from our grants team, for a study investigating the early detection of keratoconus through artificial intelligence.
Read moreAbout Us
Aotearoa Clinical Trials is a fully integrated research unit based at Middlemore Hospital in the heart of South Auckland, New Zealand.
We perform biopharma and medical device clinical trials in partnership with all hospital departments focusing on the diseases and long term health conditions that affect our diverse community.